WHY!!!
Because PHOT is the #1 MMJ pennystock out there.
As You Will Find Out!
Trading just about 75% off it's set Target Price.
PHOT trading at a huge Discount here!
It's only a matter of time till PHOT breaks
out and starts to Trend towards $.20 mark.
PHOT, an SEC fully reporting, MMJ Company,
that is taking the Market by storm.
Year-to-date 2013 revenue from sales increased
to $1,625,625 from the $300,255 recorded in the
comparable period in 2012.
For the quarter ended June 30, 2013, revenue was
$872,557, an increase of $664,111, or more than
three times the $208,446 revenue for the same
period in 2012.
Based on the Company's strong performance in the
recent quarter, significant revenue growth previous
year and excellent business outlook, GrowLife is on
track to record $5.4 million in revenues in 2013
$15 million in 2014 at impressive margins.
GrowLife expansion plans looks to double its store footprint
in the next 18 months.
The latest from CEO, Scott, indicates PHOT looks to
expand it's Business into the cultivation and sale
of Marijuana related products.
Then all bets are off, PHOT is know doubt the leading
contender for #1 mmj pennystock on the Market.
Safer than most MMJ Pennystocks, simply because PHOT
has zero regulatory tape.
It is not pushing some sort of Cannabis
chewing gum, like MJN#!
June of this year, Grass Roots Research issued a price target of $.22 cents.
And that was before PHOT just announced record revenues
for one of it's online Stores.
Looks to beat projected 5.4 million in Revenue for years
end. And has 15 million projected next year!
One of it's core products was just recently featured
in High Times Magazine.
Phototron has sold over 150,000 units, and counting!
Way undervalued here!
According to Cohen and his Grass Roots team, "PHOT's
[GrowLife's] business model is brilliant.
The Company has unique assets unavailable to most
micro cap stocks: access to capital, massive USA
and worldwide market demand, leveraged distribution
channels and a very strong management team.
GrowLife is actively engaged in improving and
expanding its lineup of branded products through
organic development, business alliances and acquisitions.
Based on the Company's strong performance in the
recent quarter, significant revenue growth previous
year and excellent business outlook, we believe that
GrowLife is on track to record $5.4 million in
revenues in 2013, $14 million in 2014 at impressive
margins.
Based on these projections and provided the Company
raises $5.0 million in capital, the Cohen Target
Price is 456.2% higher than the current price."
Based on data collected by MMJ Business Daily
from a Washington State Report, the Marijuana
Industry is expected to become a $45 billion annual
industry.
Cohen's team estimates the current size of
the medical marijuana market as $1.7 billion,
25 million potential patients, projected to grow
at 39% CAGR to $8.9
billion in 2016. The market is estimated to grow
to $29.0 billion by 2016.